Sep 30 |
Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
|
Sep 26 |
Acumen Pharmaceuticals extends collaboration with Lonza
|
Sep 26 |
Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease
|
Sep 25 |
Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024
|
Sep 3 |
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference
|
Aug 14 |
Q2 2024 Acumen Pharmaceuticals Inc Earnings Call
|
Aug 13 |
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2024 Earnings Call Transcript
|
Aug 13 |
Acumen Pharmaceuticals GAAP EPS of -$0.34 misses by $0.05
|
Aug 13 |
Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights
|
Aug 6 |
Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024
|